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Urodynamic study is the ultimate weapon for diagnosing lower urinary tract
dysfunctionWhenwe searchedMEDLINE, it was easy to ﬁnd numerous pub-
lished papers on urodynamic ﬁndings in various neurological
diseases such as diabetes, stroke, Parkinson’s disease (PD), spinal
cord injury, and multiple sclerosis. However, I often wonder how
these urodynamic data can be applied to individuals in clinical
practice. In a study of urodynamics in 50 untreated patients with
PD, Uchiyama et al1 found detrusor overactivity in 58%, an
increased bladder sensation in 12%, detrusor underactivity in 50%,
impaired urethral relaxation in 8%, and bladder outlet obstruction
in 16%. In addition, as shown in that article, three PD patients had
different urodynamic ﬁndings. The diversity of urodynamic ﬁnd-
ings makes urologists and even urodynamic specialists feel that it
is difﬁcult to speculate on a urodynamic-speciﬁc diagnosis in
a PD patient if a urodynamic study is not performed.
Elderly patients often have several medical problems. Failure to
differentiate between lower urinary tract dysfunction (LUTD) and
benign prostatic hyperplasia in studies of men with neurological
diseases might contribute to the confusion about their pathophys-
iological associations. For example, a 67-year-old male parkin-
sonism patient was bothered with frequency and urge
incontinence for 2 years. His prostate size was 52 mL, and a urody-
namic study revealed detrusor overactivity (DO) and bladder outlet
obstruction (BOO). It was difﬁcult to understand if the cause of his
DO was benign prostatic obstruction, neurodegeneration from PD,
or both, because too many confounding factors existed. Further-
more, if PD is the main cause of the LUTD, to our knowledge, data
are scarcewhethermedication for PD can improve a patient’s LUTD.
So, can we draw a tentative conclusion that every patient with
PD should receive an invasive and time-consuming urodynamic
study to achieve an accurate diagnosis before treatment? Although
it may be true theoretically, this is not practical in the real world.
Recently, Liao et al2 showed that calculation of the International
Prostate Symptom Score (IPSS) subscores and the voiding-to-
storage subscore ratio (IPSS-V/S) is a simple and useful method to
differentiate between failure to void and failure to store LUTD in
men with lower urinary tract symptoms. Homma et al3 also found
that the Overactive Bladder Symptom Score is highly sensitive to
treatment-related changes in overactive bladder symptoms and1879-5226 Copyright  2012, Taiwan Urological Association. Published by Elsevier Taiw
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Other noninvasive tools such as uroﬂowmetry, postvoiding resid-
uals, near-infrared spectroscopy, the prostate urethral angle, detru-
sor wall thickness, and intravesical prostatic protrusion have been
considered novel methods to diagnose BOO. In clinical practice
for treating parkinsonian patients, we can use these simple, avail-
able tools as guides for initial treatment. However, if satisfactory
therapeutic outcomes cannot be achieved or patients need invasive
treatment, a urodynamic study and/or videourodynamic study will
be necessary for further evaluation. So far, none of the above
methods described in recent studies can fully replace a urodynamic
investigation. Urodynamics is still the ultimate weapon in diag-
nosing LUTD.References
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